Clinical utility of MRI biomarkers for identifying NASH patients' high risk of progression: A multi-center pooled data and meta-analysis.
暂无分享,去创建一个
J. Fallowfield | R. Banerjee | A. Nakajima | A. Sanyal | G. Hirschfield | M. Noureddin | M. Kelly | S. Harrison | M. Pavlides | K. Imajo | A. Dennis | Anneli Andersson | Kento Imajo